Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Retraction notice: Downregulation of long noncoding RNA LINC01419 inhibits cell migration, invasion, and tumor growth and promotes autophagy via inactivation of the PI3K/Akt1/mTOR pathway in gastric cancer.:

Retraction notice: Downregulation of long noncoding RNA LINC01419 inhibits cell migration,... 1061903 TAM0010.1177/17588359211061903Therapeutic Advances in Medical OncologyRetraction notice research-article20212021 Therapeutic Advances in Medical Oncology Retraction Notice Ther Adv Med Oncol Retraction notice: Downregulation of long 2021, Vol. 13: 1 h DOI: 10.1177/ ttps://doi.org/10.1177 /17588359211061903 https://doi.org/10.1177/17588359211061903 noncoding RNA LINC01419 inhibits cell © The Author(s), 2021. Article reuse guidelines: migration, invasion, and tumor growth and sagepub.com/journals- permissions promotes autophagy via inactivation of the PI3K/Akt1/mTOR pathway in gastric cancer. At the request of the authors and with agreement of the editorial team, the following article has been retracted: Wang L-L, Zhang L, Cui X-F. Downregulation of long noncoding RNA LINC01419 inhibits cell migration, invasion, and tumor growth and promotes autophagy via inactivation of the PI3K/Akt1/ mTOR pathway in gastric cancer. Therapeutic Advances in Medical Oncology. 2019; 11: 1–16 (doi: 10.1177/1758835919874651). The authors and the editorial team advise that there are concerns around the scientific accuracy and legitimacy of the manuscript. journals.sagepub.com/home/tam 1 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Therapeutic Advances in Medical Oncology SAGE

Retraction notice: Downregulation of long noncoding RNA LINC01419 inhibits cell migration, invasion, and tumor growth and promotes autophagy via inactivation of the PI3K/Akt1/mTOR pathway in gastric cancer.:

Therapeutic Advances in Medical Oncology , Volume 13: 1 – Dec 15, 2021

Retraction notice: Downregulation of long noncoding RNA LINC01419 inhibits cell migration, invasion, and tumor growth and promotes autophagy via inactivation of the PI3K/Akt1/mTOR pathway in gastric cancer.:

Therapeutic Advances in Medical Oncology , Volume 13: 1 – Dec 15, 2021

Abstract

1061903 TAM0010.1177/17588359211061903Therapeutic Advances in Medical OncologyRetraction notice research-article20212021 Therapeutic Advances in Medical Oncology Retraction Notice Ther Adv Med Oncol Retraction notice: Downregulation of long 2021, Vol. 13: 1 h DOI: 10.1177/ ttps://doi.org/10.1177 /17588359211061903 https://doi.org/10.1177/17588359211061903 noncoding RNA LINC01419 inhibits cell © The Author(s), 2021. Article reuse guidelines: migration, invasion, and tumor growth and sagepub.com/journals- permissions promotes autophagy via inactivation of the PI3K/Akt1/mTOR pathway in gastric cancer. At the request of the authors and with agreement of the editorial team, the following article has been retracted: Wang L-L, Zhang L, Cui X-F. Downregulation of long noncoding RNA LINC01419 inhibits cell migration, invasion, and tumor growth and promotes autophagy via inactivation of the PI3K/Akt1/ mTOR pathway in gastric cancer. Therapeutic Advances in Medical Oncology. 2019; 11: 1–16 (doi: 10.1177/1758835919874651). The authors and the editorial team advise that there are concerns around the scientific accuracy and legitimacy of the manuscript. journals.sagepub.com/home/tam 1 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

Loading next page...
 
/lp/sage/retraction-notice-downregulation-of-long-noncoding-rna-linc01419-YJq8jy1Lfp

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
SAGE
Copyright
Copyright © 2022 by SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
ISSN
1758-8340
eISSN
1758-8359
DOI
10.1177/17588359211061903
Publisher site
See Article on Publisher Site

Abstract

1061903 TAM0010.1177/17588359211061903Therapeutic Advances in Medical OncologyRetraction notice research-article20212021 Therapeutic Advances in Medical Oncology Retraction Notice Ther Adv Med Oncol Retraction notice: Downregulation of long 2021, Vol. 13: 1 h DOI: 10.1177/ ttps://doi.org/10.1177 /17588359211061903 https://doi.org/10.1177/17588359211061903 noncoding RNA LINC01419 inhibits cell © The Author(s), 2021. Article reuse guidelines: migration, invasion, and tumor growth and sagepub.com/journals- permissions promotes autophagy via inactivation of the PI3K/Akt1/mTOR pathway in gastric cancer. At the request of the authors and with agreement of the editorial team, the following article has been retracted: Wang L-L, Zhang L, Cui X-F. Downregulation of long noncoding RNA LINC01419 inhibits cell migration, invasion, and tumor growth and promotes autophagy via inactivation of the PI3K/Akt1/ mTOR pathway in gastric cancer. Therapeutic Advances in Medical Oncology. 2019; 11: 1–16 (doi: 10.1177/1758835919874651). The authors and the editorial team advise that there are concerns around the scientific accuracy and legitimacy of the manuscript. journals.sagepub.com/home/tam 1 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

Journal

Therapeutic Advances in Medical OncologySAGE

Published: Dec 15, 2021

There are no references for this article.